Ajanta Pharma Limited (NSE:AJANTPHARM)
India · Delayed Price · Currency is INR 2,969.00
+11.20 (0.38%)
Feb 18, 2026, 12:10 PM IST
Ajanta Pharma Market Cap
Ajanta Pharma has a market cap or net worth of 369.39 billion as of February 17, 2026. Its market cap has increased by 12.55% in one year.
Market Cap
369.39B
Enterprise Value
362.45B
Revenue
52.02B
Ranking
n/a
PE Ratio
36.42
Stock Price
2,969.00
Market Cap Chart
Since April 1, 2002, Ajanta Pharma's market cap has increased from 565.80M to 369.39B, an increase of 65,187.36%. That is a compound annual growth rate of 31.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 17, 2026 | 369.39B | 6.82% |
| Dec 31, 2025 | 345.80B | -5.57% |
| Dec 31, 2024 | 366.20B | 39.58% |
| Dec 29, 2023 | 262.36B | 68.96% |
| Dec 30, 2022 | 155.28B | -19.73% |
| Dec 31, 2021 | 193.46B | 36.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mankind Pharma | 860.00B |
| Aurobindo Pharma | 688.02B |
| Alkem Laboratories | 645.95B |
| Glenmark Pharmaceuticals | 563.72B |
| Laurus Labs | 545.58B |
| Ipca Laboratories | 376.85B |
| Gland Pharma | 293.40B |
| Emcure Pharmaceuticals | 282.22B |